Alcidion acquires Silverlink Software
Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.
Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.
Silverlink is one of the largest and last remaining specialist patient administration system (PAS) providers servicing the UK NHS market. It is recognized as being a flexible, cost-effective PAS that can easily integrate with other clinical systems to support a specialist modular system approach, enabling the benefits of a full electronic patient record (EPR/EMR) without single supplier lock-in.
Oaklins’ team in Australia acted as M&A corporate advisor to Alcidion Group Ltd. on the acquisition of Silverlink Software.
![](/api/deal-hero-image/107751/deal-hero-image.jpg)
![](/api/deal-party-images/107751/deal-parties.png)
![](/api/deal-client-photo/107751/deal-client-photo.jpg)
Kate Quirke
Group Managing Director, Alcidion Group Limited
Contacter l'équipe de la transaction
Scott McInnes
Oaklins Henslow
Transactions connexes
Leika Medical Equipments Ltd. a été acquise par Angus Capital
Les actionnaires de Leika Medical Equipments Ltd. ont vendu l'entreprise à Angus Capital.
En apprendre plusPhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
En apprendre plusMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
En apprendre plus